Consequences of growth hormone deficiency for intermediary metabolism and effects of replacement

Frontiers of Hormone Research

Volumn 33, Issue , 2005, Pages 103-120

  Nørrelund, Helene ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE; HYPERGLYCEMIC AGENT; MUSCLE PROTEIN; PROTEIN; UREA;

ADIPOSE TISSUE; ADULT; DIET RESTRICTION; DRUG EFFECT; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; LIPOLYSIS; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADIPOSE TISSUE; ADULT; FASTING; GLUCOSE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN ANTAGONISTS; LIPID METABOLISM; LIPOLYSIS; MUSCLE PROTEINS; OBESITY; PROTEINS; UREA;

EID: 27744451188     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (104)

1. Collip PJ, Curti V, Thomason M: Body composition changes in children receiving growth hormone. Metabolism, 1973;22:589-595.
2. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BA: Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1993;38:63-71.
3. Fowelin J, Attwall S, Lager I, Bengtsson BA: Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 1993;42:1443-1447.
4. Beshyah SA, Henderson A, Niththyanathan R, Sharp P, Richmond W, Johnston D: Metabolic abnormalities in growth hormone-deficient adults. II Carbohydrate tolerance and lipid metabolism. Endocrinol Metabol 1994;1:173-180.
5. Bratusch-Marrain PR, Smith D, De Fronzo RA: The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 1982;55:973-982.
6. Rizza RA, Mandarino LJ, Gerich JE: Effects of growth hormone on insulin action in man: Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 1982;31:663-669.
7. Copeland KC, Nair KS: Acute growth hormone effects on amino acid and lipid metabolism. J Clin Endocrinol Metab 1994;78:1040-1047.
8. Butler AA, Le Roith D: Control of growth by the somatropic axis: Growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 2001;63:141-164.
9. Cummings DE, Merriam GR: Growth hormone therapy in adults. Annu Rev Med 2003;54:513-533.
10. Hartman ML, Veldhuis JD, Johnson ML, Lee MM, Alberti KG, Samojlik E, Thorner MO: Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab 1992;74:757-765.
11. Veldhuis JD, Iranmanesh A, Ho KY: Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991;72:51-59.
12. Horber FF, Haymond MW: Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990;86:265-272.
13. Yarasheski KE, Campbell JA, Smith K, Rennie MJ, Holloszy JO, Bier DM: Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol 1992;262:E261-E267.
14. Fryburg DA, Gelfand RA, Barrett EJ: Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991;260:E499-E504.
15. Fryburg DA, Louard RJ, Gerow KE, Gelfand RA, Barrett EJ: Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes 1992;41:424-429.
16. Garibotto G, Barreca A, Russo R, Sofia A, Araghi P, Cesarone A, Malaspina M, Fiorini F, Minuto F, Tizianello A: Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 1997;99:97-105.
17. Zachwieja JJ, Bier DM, Yarasheski KE: Growth hormone administration in older adults: Effects on albumin synthesis. Am J Physiol 1994;266:E840-E844.
18. Nielsen S, Jørgensen JO, Hartmund T, Nørrelund H, Nair KS, Christiansen JS, Møller N: Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients. Growth Horm IGF Res 2002;12:425-433.
19. Hoffman DM, Pallasser R, Duncan M, Nguyen TV, Ho KK: How is whole body protein turnover perturbed in growth hormone-deficient adults ? J Clin Endocrinol Metab 1998;83:4344-4349.
20. Beshyah SA, Sharp PS, Gelding SV, Halliday D, Johnston DG: Whole-body leucine turnover in adults on conventional treatment for hypopituitarism. Acta Endocrinol 1993;129:158-164.
21. Russell-Jones DL, Weissberger AJ, Bowes SB, Kelly JM, Thomason M, Umpleby AM, Jones RH, Sonksen PH: The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 1993;38:427-431.
22. Lucidi P, Lauteri M, Laureti S, Celleno R, Santoni S, Volpi E, Angeletti G, Santeusanio F, De Feo P: A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J Clin Endocrinol Metab 1998;83:353-357.
23. Shi J, Sekhar RV, Balasubramanyam A, Ellis K, Reeds PJ, Jahoor F, Sharma MD: Short- and long-term effects of growth hormone (GH) replacement on protein metabolism in GH-deficient adults. J Clin Endocrinol Metab, 2003;88:5827-5833.
24. Manson JM, Wilmore DW: Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery 1986;100:188-197.
25. Lundeberg S, Belfrage M, Wernerman J, von der Decken A, Thunell S, Vinnars E: Growth hormone improves muscle protein metabolism and whole body nitrogen economy in man during a hyponitrogenous diet. Metabolism 1991;40:315-322.
26. Nørrelund H, Nair KS, Jørgensen JOL, Christiansen JS, Møller N: The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 2001;50:96-104.
27. Nørrelund H, Møller N, Nair KS, Christiansen JS, Jørgensen JOL: Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis. J Clin Endocrinol Metab 2001;86:3120-3129.
28. Nørrelund H, Djurhuus C, Jørgensen JOL, Nielsen S, Nair KS, Schmitz O, Christiansen JS, Møller N: Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients. Am J Physiol 2003;285:E737-E743.
29. Felig P, Marliss EB, Cahill GF Jr: Metabolic response to human growth hormone during prolonged starvation. J Clin Invest 1971;50:411-421.
30. Snyder DK, Clemmons DR, Underwood LE: Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: Effects on anabolism, lipolysis, and body composition. J Clin Endocrinol Metab 1988;67:54-61.
31. Clemmons DR, Snyder DK, Williams R, Underwood LE: Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J Clin Endocrinol Metab 1987;64:878-883.
32. Tagliaferri M, Scacchi M, Pincelli AI: Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women. Int J Obes 1998;22:836-841.
33. Nørrelund H, Børglum J, Jørgensen JOL, Richelsen B, Møller N, Nair KS, Christiansen JS: Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women. Clin Endocrinol 2000;52:305-312.
34. Shiman R, Gray DW: Substrate activation of phenylalanine hydroxylase. J Biol Chem 1980;255:4793-4800.
35. Wolthers T, Grøfte T, Jørgensen JOL, Vilstrup H: Growth hormone prevents prednisolone-induced increase in functional hepatic nitrogen clearance in normal man. J Hepatol 1997;27:789-795.
36. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG: Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003;349:1139-1147.
37. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R: Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002;277:49831-49840.
38. Liu W, Thomas SG, Asa SL, Gonzalez-Cadavid N, Bhasin S, Ezzat S: Myostatin is a skeletal muscle target of growth hormone anabolic action. J Clin Endocrinol Metab 2003;88:5490-5496.
39. Sherwin RS, Hendler RG, Felig P: Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest 1975;55:1382-1390.
40. Nair KS, Welle SL, Halliday D, Campbell RG: Effect of beta-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans. J Clin Invest 1988;82:198-205.
41. Ferrannini E, Barrett EJ, Bevilacqua S, Jacob R, Walesky M, Sherwin RS, DeFronzo RA: Effect of free fatty acids on blood amino acid levels in human. Am J Physiol 1986;250:E686-E694.
42. Wicklmayr M, Rett K, Schwiegelsohn B: Inhibition of muscular amino acid release by lipid infusion in man. Eur J Clin Invest 1987;17:301-305.
43. Tessari P, Nissen SL, Miles JM, Haymond MW: Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest 1986;77:575-581.
44. Fery F, Plat L, Baleriaux M, Balasse EO: Inhibition of lipolysis stimulates whole body glucose production and disposal in normal postabsorptive subjects. J Clin Endocrinol Metab 1997;82:825-830.
45. Fery F, Plat L, Melot C, Balasse EO: Role of fat-derived substrates in the regulation of gluconeogenesis during fasting. Am J Physiol 1996;270:E822-E830.
46. Nørrelund H, Nair KS, Nielsen S, Frystyk J, Ivarsen P, Jørgensen JOL, Christiansen JS, Møller N: The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. J Clin Endocrinol Metab 2003;88:4371-4378.
47. Butler P, Kryshak E, Rizza RA: Mechanism of growth hormone-induced post-prandial carbohydrate intolerance in humans. Am J Physiol 1991;260:E513-E520.
48. Ørskov L, Schmitz O, Jørgensen JOL, Arnfred J, Abildgård N, Christiansen JS, Alberti KG, Ørskov H: Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique. J Clin Endocrinol Metab 1989;68:276-281.
49. Salomon F, Cuneo RC, Umpleby AM, Sonksen PH: Glucose and fat metabolism in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1994;41:315-322.
50. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW: The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 1992;37:79-87.
51. Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M: Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 1992;126:387-393.
52. Rosen T, Johannsson G, Hallgren P, Caidahl K, Bosaeus I, Bengtsson BA: Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol Metab 1994;1:55-66.
53. Verhelst J, Abs R, Vandeweghe M, Mockel J, Legros JJ, Copinschi G, Mahler C, Velkeniers B, Vanhaelst L, Van Aelst A, De Rijdt D, Stevenaert A, Beckers A: Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1997;47:485-494.
54. Nørrelund H, Vahl N, Juul A, Møller N, Alberti KGMM, Skakkebæk NE, Christiansen JS, Jørgensen JO L: Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: Impact on insulin sensitivity and substrate metabolism. J Clin Endocrinol Metab 2000;85:1912-1917.
55. Jørgensen JOL, Pedersen SB, Børglum J, Møller N, Schmitz O, Christiansen JS, Richelsen B: Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: A double-blind placebo-controlled study. Metabolism 1994;43:872-877.
56. Johannsson G, Marin P, Lonn L, Ottoson M, Stenlof K, Bjorntop P, Sjostrom L, Bengtsson BA: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 1997;82:727-734.
57. Svensson J, Lonn L, Jansson JO: Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab 1998;83:362-369.
58. Haymond MW, Karl I, Weldon VV, Pagliari AS: The role of growth hormone and cortisone on glucose and gluconeogenic substrate regulation in fasted hypopituitary children. J Clin Endocrinol Metab 1976;42:846-856.
59. Bougneres PF, Artavia-Loria E, Ferre P, Chaussain JL, Job JC: Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood. J Clin Endocrinol Metab 1985;61:1152-1157.
60. Jørgensen JOL, Møller J, Alberti KG, Schmitz O, Christiansen JS, Ørskov H, Møller N: Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: Studies in GH-deficient patients and healthy untreated subjects. J Clin Endocrinol Metab 1993;77:1589-1596.
61. Rathgeb I, Steele R, Winkler B, Altszuler N: Influence of fasting on changes in glucose metabolism induced by growth hormone injection in the normal dog. Diabetes 1970;19:487-491.
62. Snyder DK, Clemmons DR, Underwood LE: Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans. J Clin Endocrinol Metab 1989;69:745-752.
63. Snyder DK, Underwood LE, Clemmons DR: Anabolic effects of growth hormone in obese diet-restricted subjects are dose-dependent. Am J Clin Nutr 1990;52:431-437.
64. Schoenle E, Zapf J, Froesch ER: Glucose transport in adipocytes and its control by growth hormone in vivo. Am J Physiol 1982;242:E368-E372.
65. Schwartz J, Foster CM: Pituitary and recombinant deoxyribonucleic acid-derived human growth hormone alter glucose metabolism in 3T3 adipocytes. J Clin Endocrinol Metab 1986;62:791-794.
66. Schoenle E, Qing QR, Zachmann M: Growth hormone requirement for a normal human adipocyte glucose carrier function. J Clin Endocrinol Metab 1990;70:1674-1677.
67. Foster CM, Hale PM, Jing HW, Schwartz J: Effects of human growth hormone on insulin-stimulated glucose metabolism in 3T3-F442A adipocytes. Endocrinology 1988;123:1082-1088.
68. Silverman MS, Mynarcik DC, Corin RE, Haspel HC, Sonenberg M: Antagonism by growth hormone of insulin sensitive hexose transport in 3T3-F442A adipocytes. Endocrinology 1989;125:2600-2604.
69. Magri KA, Adamo M, LeRoith D, Etherton TD: The inhibition of insulin action and glucose metabolism by porcine growth hormone in porcine adipocytes is not the result of any decrease in insulin binding or insulin receptor kinase activity. Biochem J 1990;266:107-113.
70. Smith TR, Elmendorf JS, David TS, Turinsky J: Growth hormone-induced insulin resistance: Role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Am J Physiol 1997;272:E1071-E1079.
71. Goodman HM: Effects of growth hormone on glucose utilization in diaphragm muscle in the absence of increased lipolysis. Endocrinology 1967;81:1099-1103.
72. Bak JF, Moller N, Schmitz O: Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol 1991;260:E736-E742.
73. Kim JK, Choi CS, Youn JH: Acute effect of growth hormone to induce peripheral insulin resistance is independent of FFA and insulin levels in rats. Am J Physiol 1999;277:E742-E749.
74. Møller N, Jørgensen JOL, Schmitz O, Møller J, Christiansen JS, Alberti KG, Ørskov H: Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol 1990;258:E86-E91.
75. Fowelin J, Attvall S, von Schenck H, Smith U, Lager I: Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia 1991;34:500-506.
76. Neely RD, Rooney DP, Bell PM, Bell NP, Sheridan B, Atkinson AB, Trimble ER: Influence of growth hormone on glucose-glucose 6-phosphate cycle and insulin action in normal humans. Am J Physiol 1992;263:E980-E987.
77. Yki-Jarvinen H, Puhakainen I, Koivisto VA: Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab 1991;72:1268-1277.
78. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C: Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 1991;88:960-966.
79. Vaag A, Skott P, Damsbo P, Gall MA, Richter EA, Beck-Nielsen H: Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin dependent diabetes mellitus. J Clin Invest 1991;88:1282-1290.
80. Piatti PM, Monti LD, Caumo A, Conti M, Magni F, Galli-Kienle M, Fochesato E, Pizzini A, Baldi L, Valsecchi G, Pontiroli AE: Mediation of the hepatic effects of growth hormone by its lipolytic activity. J Clin Endocrinol Metab 1999;84:1658-1663.
81. Santomauro AT, Boden G, Silva MER, Rocha DM, Santos RF, Ursich MJM, Strassmann PG, Wajchenberg BL: Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 1999;48:1836-1841.
82. Nielsen S, Møller N, Christiansen JS, Jørgensen JO: Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 2001;50:2301-2308.
83. Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC: Inhibition of the rise in FFA by acipimox partially prevents GH-induced insulin resistance in GH-deficient adults. J Clin Endocrinol Metab 2001;86:5813-5818.
84. Nørrelund H, Nielsen S, Christiansen JS, Jørgensen JOL, Møller N: Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting. Eur J Endocrinol 2004;150:779-787.
85. Møller N, Schmitz O, Møller J, Pørksen N, Jørgensen JOL: Dose-response studies on the metabolic effects of a growth hormone pulse in humans. Metabolism 1992;41:172-175.
86. Rosenthal MJ, Woodside WF: Nocturnal regulation of free fatty acids in healthy young and elderly men. Metabolism 1988;37:645-648.
87. Ho KK, O'Sullivan AJ, Hoffman DM: Metabolic actions of growth hormone in man. Endocr J 1996;43:S57-S63.
88. Jørgensen JOL, Møller N, Lauritzen T, Alberti KG, Ørskov H, Christiansen JS: Evening versus morning injections of growth hormone (GH) in GH-deficient patients: Effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 1990;70:207-214.
89. Salomon F, Cuneo RC, Hesp R, Sonksen PH: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797-1803.
90. Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebæk NE, Christiansen JS: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, 1989;i:1221-1225.
91. Reaven G: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
92. Rosen T, Bengtsson BA: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-288.
93. Markussis V, Beshyah SA, Fisher C, Sharp PS, Nicolaides A, Johnston DG: Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992;340:1188-1192.
94. Johnston P, Hollenbeck C, Sheu W, Chen Y-D. I, Reaven G: Acute changes in plasma non-esterified fatty acid concentration do not change hepatic glucose production in people with type 2 diabetes. Diabet Med 1990;7:871-875.
95. Richelsen B, Pedersen SB, Børglum J: Growth hormone treatment of obese women for 5 wk: Effect on body composition and adipose tissue LPL activity. Am J Physiol 1994;266:E211-E216.
96. Møller N, Pørksen N, Ovesen P, Alberti KG: Evidence for increased sensitivity of fuel mobilization to growth hormone during short-term fasting in humans. Horm Metab Res 1993;25:175-179.
97. VanderLaan WP, Simpson DP: Restoration by growth hormone of normal responses to fasting in a pituitary dwarf. Abstracts 81st Annu Meet Endocrine Society 1999.
98. Richelsen B, Pedersen SB, Kristensen K, Børglum JD, Nørrelund H, Christiansen JS, Jørgensen JOL: Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism 2000;49:906-911.
99. Lee V, Ramachandran J, Li CH: Human pituitary growth hormone. Intrinsic lipolytic activity on rabbit fat cells. Arch Biochem Biophys 1975;169:669-677.
100. Goodman HM: Separation of early and late responses of adipose tissue to growth hormone. Endocrinology 1981;109:120-129.
101. Hart IC, Chadwick PM, Boone TC, Langley KE, Rudman C, Souza LM: A comparison of the growth promoting, lipolytic, diabetogenic and immunological properties of pituitary and recombinant-DNA-derived bovine growth hormone (somatotropin). Biochem J 1984;224:93-100.
102. Chipkin SR, Szecowka J, Tai LR, Kostyo JL, Goodman HM: Different growth hormone-receptor interactions mediate insulin-like and lipolytic responses of rat adipose tissue. Endocrinology 1989;125:450-458.
103. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose-fatty acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1963;i:785-789.
104. Fryburg DA Barrett EJ: Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans. Metabolism 1993;42:1223-1227.